Department of Surgery, University of California San Francisco, Fresno, CA.
Department of Surgery, University of California San Francisco, Fresno, CA.
J Am Coll Surg. 2020 Jul;231(1):150-154. doi: 10.1016/j.jamcollsurg.2019.12.044. Epub 2020 Feb 17.
Rib fractures are common among trauma patients and analgesia remains the cornerstone of treatment. Intercostal nerve blocks provide analgesia but are limited by the duration of the anesthetic. This study compares outcomes of epidural analgesia with intercostal nerve block using liposomal bupivacaine for the treatment of traumatic rib fractures.
A retrospective chart review was used to identify patients who received either epidural analgesia or intercostal nerve block with liposomal bupivacaine for the treatment of traumatic rib fractures. Patients were matched in a 1:1 ratio on age, Injury Severity Score, and number of rib fractures. Outcomes included intubations, mechanical ventilation days, ICU length of stay (LOS), hospital LOS, and mortality.
After matching, 116 patients were included in the study. Patients receiving intercostal nerve blocks with liposomal bupivacaine were less likely to require intubation (3% vs 17%; p = 0.015), had shorter hospital LOS (mean ± SD 8 ± 6 days vs 11 ± 9 days; p = 0.020) and ICU LOS (mean ± SD 2 ± 5 days vs 5 ± 6 days; p = 0.007). There were no differences in ventilator days or mortality. Minor complications occurred in 26% of patients that received an epidural catheter for rib fractures. No complications occurred in the patients receiving intercostal nerve block.
Patients who received intercostal nerve blocks with liposomal bupivacaine required intubation less frequently and had shorter ICU and hospital LOS compared with epidural analgesia patients. These results suggest that intercostal nerve blocks with liposomal bupivacaine might be equal or superior to epidural analgesia.
肋骨骨折在创伤患者中很常见,镇痛仍然是治疗的基石。肋间神经阻滞提供镇痛,但受麻醉持续时间的限制。本研究比较了使用脂质体布比卡因的硬膜外镇痛与肋间神经阻滞治疗创伤性肋骨骨折的结果。
回顾性病历分析用于确定接受硬膜外镇痛或肋间神经阻滞联合脂质体布比卡因治疗创伤性肋骨骨折的患者。按照年龄、损伤严重程度评分和肋骨骨折数量进行 1:1 匹配。结果包括插管、机械通气天数、重症监护病房(ICU)住院时间(LOS)、医院 LOS 和死亡率。
匹配后,116 例患者纳入研究。接受脂质体布比卡因肋间神经阻滞的患者插管的可能性较小(3%比 17%;p=0.015),住院 LOS(均值±标准差 8±6 天比 11±9 天;p=0.020)和 ICU LOS(均值±标准差 2±5 天比 5±6 天;p=0.007)较短。通气天数和死亡率无差异。接受硬膜外导管治疗肋骨骨折的患者中有 26%发生轻微并发症。接受肋间神经阻滞的患者无并发症发生。
与硬膜外镇痛患者相比,接受脂质体布比卡因肋间神经阻滞的患者插管频率较低,ICU 和医院 LOS 较短。这些结果表明,脂质体布比卡因肋间神经阻滞可能与硬膜外镇痛相当或更优。